The Difference between Plan b and ella (R)? They're Basically the Same Thing: Results from a Mystery Client Study
Publisher
MDPICitation
Kaur, G.; Fontanilla, T.; Bullock, H.; Tschann, M. “The Difference between Plan b and ella®? They’re Basically the Same Thing”: Results from a Mystery Client Study. Pharmacy 2020, 8, 77.Journal
PHARMACYRights
Copyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Pharmacy staff can serve an important role educating patients about emergency contraceptive pills (ECP), particularly ulipristal acetate (UPA), which requires a prescription. We conducted a secondary analysis of a previously completed mystery client study, assessing accuracy of information provided by pharmacy staffers to patients inquiring by telephone about filling a prescription for UPA. From the period December 2013 to July 2014, researchers used a mystery client methodology, contacting 198 retail pharmacies in HawaiModified Letter Turned Commai. Researchers posed as patients or providers attempting to fill a prescription for UPA. During the course of the call, they asked about differences between UPA and levonorgestrel ECPs. Nearly half of all pharmacy staffers were unfamiliar with UPA. The majority of responses describing differences between the medications were incorrect or misleading, such as responses implying that UPA is an abortifacient. Lack of familiarity and incorrect information provided by pharmacy staffers may act as additional barriers in patient access to UPA. Health practitioners prescribing UPA should ensure patients receive evidence-based counseling at the time of prescription, while efforts should also be made to improve pharmacy staff familiarity with emergency contraceptive options.Note
Open access journalISSN
2226-4787EISSN
2226-4787PubMed ID
32369906Version
Final published versionae974a485f413a2113503eed53cd6c53
10.3390/pharmacy8020077
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Copyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Related articles
- From Kaua'i to Hawai'i Island: Interisland Differences in Emergency Contraceptive Pill Availability.
- Authors: Bullock H, Tschann M, Elia J, Kaneshiro B, Salcedo J
- Issue date: 2017 Jul
- Pharmacy access to Ulipristal acetate in major cities throughout the United States.
- Authors: Shigesato M, Elia J, Tschann M, Bullock H, Hurwitz E, Wu YY, Salcedo J
- Issue date: 2018 Mar
- Pharmacy access to ulipristal acetate in Hawaii: is a prescription enough?
- Authors: Bullock H, Steele S, Kurata N, Tschann M, Elia J, Kaneshiro B, Salcedo J
- Issue date: 2016 May
- Exploring the Availability of Emergency Contraception in New Brunswick Pharmacies: A Mystery-Client Telephone Study.
- Authors: Borsella M, Foster AM
- Issue date: 2020 Apr 30
- Emergency Contraception Access and Counseling in Metropolitan and Nonmetropolitan Pharmacies in Georgia.
- Authors: Stone RH, Gross S, Reardon B, Young HN
- Issue date: 2023 Jun

